Evidence map›Paper›PMID 40670790›Full record

ArticleNature2025

Prophages block cell surface receptors to preserve their viral progeny.

Véronique L Taylor, Pramalkumar H Patel, Megha Shah, Ahmed Yusuf, Cayla M Burk, Kristina M Sztanko, Zemer Gitai, Alan R Davidson, Matthias D Koch, Karen L Maxwell

Abstract read
In one paragraph

Article in Nature, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Prophage-Derived Molecules as Anti-Antibiotics (Basel, Switzerland) · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. mBio · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Véronique L TaylorDepartment of Biochemistry, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0002-0470-9346
Pramalkumar H PatelDepartment of Biochemistry, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0001-6400-3081
Megha ShahDepartment of Biochemistry, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0003-3090-9912
Ahmed YusufDepartment of Biology, Texas A&M University, College Station, TX, USA.ORCID 0009-0007-0288-526X
Cayla M BurkDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.ORCID 0009-0003-4457-6909
Kristina M SztankoDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Zemer GitaiDepartment of Molecular Biology, Princeton University, Princeton, NJ, USA.ORCID 0000-0002-3280-6178
Alan R DavidsonDepartment of Biochemistry, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0002-0744-9199
Matthias D KochDepartment of Biology, Texas A&M University, College Station, TX, USA.
Karen L MaxwellDepartment of Biochemistry, University of Toronto, Toronto, Ontario, Canada. karen.maxwell@utoronto.ca.ORCID 0000-0002-0211-5480

Funding

Understanding type IV pili on the singe-molecule levelR35GM155280 · NIGMS · TEXAS A&M UNIVERSITY · PI Matthias Daniel Koch · 2024 to 2026
$1.1M
NIGMS NIH HHS R35 GM155280
6 · The paper itself

Abstract

In microbial communities, viruses compete for host cells and have evolved diverse mechanisms to inhibit competitors. One strategy is superinfection exclusion, whereby an established viral infection prevents a secondary infection of the same cell

Indexed as

BacteriophagesProphagesReceptors, Cell SurfaceReceptors, VirusBacteriaFimbriae, BacterialLysogenySuperinfectionViral ProteinsVirus InternalizationReceptors, Cell SurfaceReceptors, VirusViral Proteins

Identifiers

PMID40670790
PMCPMC13292811

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.